Turing Pharmaceuticals LLC CEO Martin Shkreli discusses why the company increased the price of a drug from $13.50 to $750 a tablet. He speaks on "Bloomberg Markets." (Source: Bloomberg)
49:01 - Bloomberg’s Arabile Gumede discusses South Africa’s ratings amid political strife. He speaks with Bloomberg's Alix Steel, David Westin and Jonathan Ferro on "Bloomberg Daybreak: Americas." (Source: Bloomberg)
RBI Turns Hawkish on Inflation, Has Food Price Concerns
Full Show: What'd You Miss? (04/06)
Most Preferred Security Shows No Signs of Fizzling